ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GWP GW Pharm.

735.00
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
GW Pharm. LSE:GWP London Ordinary Share GB0030544687 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 735.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

GW Pharmaceuticals PLC Director/PDMR Shareholding (3721Q)

29/08/2014 12:20pm

UK Regulatory


Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Gw Pharmaceuticals Charts.

TIDMGWP

RNS Number : 3721Q

GW Pharmaceuticals PLC

29 August 2014

GW Pharmaceuticals PLC Director/PDMR Shareholding

GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company", "GW")

NOTIFICATION OF INTERESTS OF DIRECTORS

Porton Down, UK, 29 August 2014: GW Pharmaceuticals (NASDAQ: GWPH, AIM: GWP) hereby provides notification that it was informed yesterday that Dr Geoffrey Guy, a Director and Chairman of the Board, gifted 100,000 GW Pharmaceuticals 0.1 pence ordinary shares to the Royal Society of Medicine and 75,000 shares to Weldmar Hospicecare Trust on 29 August 2014. The total number of shares gifted of 175,000 represents less than 0.1% of the Company's issued share capital. The shares were gifted when the price of the shares was 468.75 pence per share. Following this charitable gift, Dr Guy continues to retain a beneficial interest in 14,443,648 0.1 pence ordinary shares, representing 6.1% of the issued share capital.

Enquiries:

GW Pharmaceuticals PLC

   Adam George, CFO/Company Secretary                                Tel: +44 (0)1980 557 000 
   Stephen Schultz, VP Investor Relations                                 Tel: 917 280 2424 
   Peel Hunt LLP (Nominated Adviser)                                        Tel: +44 (0)207 418 8900 

James Steel / Oliver Jackson

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLFLLTAIAFIS

1 Year Gw Pharmaceuticals Chart

1 Year Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart

1 Month Gw Pharmaceuticals Chart